1. Research Areas  

Focuses on the prevention and treatment of dog and cat diseases, as well as the development of biologics.

      Basic research fields: molecular epidemiology and etiology, infection and immune mechanisms of canine parvovirus and canine distemper virus;

      Development of biologics : diagnosis kits, recombinant protein and antibody drugs, and engineered vaccines. 

  2. Current Members

      8 team members, 1 Professor, 3 associate professors and 5 PhD

   3. Development of biologics

• Diagnosis kits, recombinant protein, antibodies, and engineered vaccines. 

• Molecular diagnostic kits for more than 30 pathogens were developed , including dogs, cats, respiratory tract, digestive tract, insect borne and human pet borne diseases; 

•  Recombinant proteins and antibodies development platform for recombinant cytokines such as CSF, IFN, IL, neutralizing mAb such as CDV, CPV, FPV, and canine derived target blocking mAb such as PD-1 and NGF. 

•  Develop VLPs and other nanoparticle vaccines and FHV live vector multivalent vaccines. 

•  more than 20 national invention patents, 1 clinical trial approval  and 2 achievements transformation.